Prospective, Multicenter Evaluation of Transcarotid Artery Revascularization (TCAR) In Standard-Risk Patients: 1-Year Outcomes of the ROADSTER 3 Study

Monday, November 3, 2025

4:45pm - 4:55pm PT

Speaker(s)

Meghan Dermody, MD

Chief, Division of Vascular Surgery
Penn Medicine Lancaster General Hospital

Disclosure(s): Boston Scientific: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

Disclosure(s):

Meghan Dermody, MD: Boston Scientific: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)